JMDC Inc. (TSE:4483) agreed to acquire Cancer Scan Co., Ltd. for ¥ 14000 million on December 28, 2023. JMDC Inc. (TSE:4483) will acquire 0.11 million shares of Cancer Scan Co., Ltd. The total assets were ¥ 2695 million, net assets were ¥ 2,097 million, revenue was ¥ 4,177 million, operating profit was ¥ 696 million and net income was ¥ 454 million for year ending May 31, 2023 of Cancer Scan Co., Ltd. The deal is expected to be closed on January 31, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,952 JPY | -1.75% | -8.02% | -30.74% |
May. 08 | JMDC to Pay Final Dividend of 14 Yen Per Share in June | MT |
May. 07 | JMDC's Profit Up 8% in Fiscal 2024 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.74% | 1.24B | |
+16.85% | 4.48B | |
-21.41% | 2.27B | |
+20.89% | 1.89B | |
-5.42% | 1.67B | |
+0.03% | 1.57B | |
-20.35% | 1.52B | |
-8.07% | 1.16B | |
-12.05% | 968M | |
-10.89% | 746M |
- Stock Market
- Equities
- 4483 Stock
- News JMDC Inc.
- JMDC Inc. agreed to acquire Cancer Scan Co., Ltd. for ¥ 14000 million.